Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis

被引:70
作者
Devesa, I
Ferrándiz, ML
Terencio, MC
Joosten, LAB
van den Berg, WB
Alcaraz, MJ
机构
[1] Univ Valencia, Dept Pharmacol, E-46100 Burjassot, Valencia, Spain
[2] Univ Nijmegen, Radboud Med Ctr, Nijmegen, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 10期
关键词
D O I
10.1002/art.21356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Heme oxygenase 1 (HO-1) can be induced by inflammatory mediators as an adaptive response. The objective of the present study was to determine the consequences of HO-1 modulation in the murine collagen-induced arthritis (CIA) model. Methods. DBA/1J mice were treated with an inhibitor of HO-1, tin protoporphyrin IX (SnPP), or with an inducer of HO-1, cobalt protoporphyrin IX (CoPP), from day 22 to day 29 after CIA induction. The clinical evolution of disease was monitored visually. At the end of the experiment, joints were examined for histopathologic changes. Cytokine levels in paws were measured by enzyme-linked immunosorbent assay. Levels of HO-1, cyclooxygenase 2 (COX-2), and prostaglandin E-2 (PGE(2)) were determined. Effects of treatments on the early phase of disease and after prophylactic administration were also assessed. Results. CoPP strongly induced HO-1, resulting in the inhibition of cartilage erosion accompanied by extensive fibrosis in the joint. Levels of tumor necrosis factor a (TNF alpha), interleukin-2 (IL-2), and IL-10 were inhibited by CoPP, whereas levels of vascular endothelial growth factor were increased. Treatment with SnPP significantly reduced the severity of CLA, with inhibition of joint inflammation and cartilage destruction. The levels of PGE(2) IL-1 beta, and TNFa were also significantly reduced by SnPP treatment, which did not modify COX-2 protein expression. SnPP was more effective than CoPP in preventing the development of CIA (prophylactic administration). Conclusion. HO-1 is induced during CIA. Although overexpression of this protein causes some beneficial effects, strategies aimed at HO-1 overexpression cannot slow the progression of the chronic inflammatory disease, whereas treatment with SnPP, which inhibits HO-1, exerts prophylactic and therapeutic effects.
引用
收藏
页码:3230 / 3238
页数:9
相关论文
共 49 条
  • [1] Anti-inflammatory actions of the heme oxygenase-1 pathway
    Alcaraz, MJ
    Fernandez, P
    Guillén, MI
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (30) : 2541 - 2551
  • [2] Enhanced expression of haem oxygenase-1 by nitric oxide and antiinflammatory drugs in NIH 3T3 fibroblasts
    Alcaraz, MJ
    Habib, A
    Lebret, M
    Créminon, C
    Lévy-Toledano, S
    Maclouf, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) : 57 - 64
  • [3] Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration
    Bussolati, B
    Ahmed, A
    Pemberton, H
    Landis, RC
    Di Carlo, F
    Haskard, DO
    Mason, JC
    [J]. BLOOD, 2004, 103 (03) : 761 - 766
  • [4] Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis
    Devesa, I
    Ferrándiz, ML
    Guillén, I
    Cerdá, JM
    Alcaraz, MJ
    [J]. LABORATORY INVESTIGATION, 2005, 85 (01) : 34 - 44
  • [5] Rheumatoid arthritis
    Feldmann, M
    Brennan, FM
    Maini, RN
    [J]. CELL, 1996, 85 (03) : 307 - 310
  • [6] Feldmann M, 1999, ANN RHEUM DIS, V58, P27
  • [7] Feldmann M, 1999, RHEUMATOLOGY, V38, P3
  • [8] Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis - A large, international, multicenter, placebo-controlled trial
    Fleischmann, RM
    Schechtman, J
    Bennett, R
    Handel, ML
    Burmester, GR
    Tesser, J
    Modafferi, D
    Poulakos, J
    Sun, G
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (04): : 927 - 934
  • [9] Foey AD, 1998, J IMMUNOL, V160, P920
  • [10] Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice
    Inoue, S
    Suzuki, M
    Nagashima, Y
    Suzuki, S
    Hashiba, T
    Tsuburai, T
    Ikehara, K
    Matsuse, T
    Ishigatsubo, Y
    [J]. HUMAN GENE THERAPY, 2001, 12 (08) : 967 - 979